Don Dahler has a look at the drug company practice of buying the rights to drugs and then drastically increasing their prices. Despite the trend, one drug company takes a different approach. Source
Don Dahler has a look at the drug company practice of buying the rights to drugs and then drastically increasing their prices. Despite the trend, one drug company takes a different approach. Source